- Home
- ZD vs TXG Comparison
ZD vs TXG Comparison
Compare ZD & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZD
- TXG
- Stock Information
- Founded
- ZD 1995
- TXG 2012
- Country
- ZD United States
- TXG United States
- Employees
- ZD N/A
- TXG N/A
- Industry
- ZD Advertising
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- ZD Consumer Discretionary
- TXG Industrials
- Exchange
- ZD Nasdaq
- TXG Nasdaq
- Market Cap
- ZD 1.6B
- TXG 1.6B
- IPO Year
- ZD 1999
- TXG 2019
- Fundamental
- Price
- ZD $39.26
- TXG $12.75
- Analyst Decision
- ZD Hold
- TXG Buy
- Analyst Count
- ZD 5
- TXG 12
- Target Price
- ZD $41.80
- TXG $13.54
- AVG Volume (30 Days)
- ZD 535.9K
- TXG 2.7M
- Earning Date
- ZD 11-06-2025
- TXG 10-28-2025
- Dividend Yield
- ZD N/A
- TXG N/A
- EPS Growth
- ZD N/A
- TXG N/A
- EPS
- ZD 1.48
- TXG N/A
- Revenue
- ZD $1,447,248,000.00
- TXG $644,466,000.00
- Revenue This Year
- ZD $8.37
- TXG $2.15
- Revenue Next Year
- ZD $3.95
- TXG N/A
- P/E Ratio
- ZD $26.56
- TXG N/A
- Revenue Growth
- ZD 5.94
- TXG 2.02
- 52 Week Low
- ZD $28.55
- TXG $6.78
- 52 Week High
- ZD $60.62
- TXG $20.92
- Technical
- Relative Strength Index (RSI)
- ZD 59.61
- TXG 50.65
- Support Level
- ZD $35.34
- TXG $11.22
- Resistance Level
- ZD $39.12
- TXG $13.36
- Average True Range (ATR)
- ZD 1.36
- TXG 0.55
- MACD
- ZD 0.06
- TXG -0.01
- Stochastic Oscillator
- ZD 81.75
- TXG 62.70
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).